Glucotrack (GCTK) Return on Equity [ROE] (2011 - 2026)
Glucotrack's Return on Equity [ROE] came in at -2942.41% for Q2 2026, down 2724.58 percentage points from -217.83% a year earlier.
Powered by 
Analysis
Glucotrack (GCTK) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2023, Glucotrack's Return on Equity [ROE] was -320.94%, down 182.11 percentage points from FY2022.
- Return on Equity [ROE] carries a three-year change of -238.19 percentage points (FY2020 to FY2023).
- Going back by year, Return on Equity [ROE] was -138.83% in FY2022 (-81.67 pp), -57.15% in FY2021 (+25.59 pp) and -82.75% in FY2020.
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q4 2011.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2024 (a gain of 253.95 percentage points), and the weakest in Q2 2026 (a drop of 2724.58 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 13.36% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 10.39% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 7.56% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 17.60% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 10.44% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | -3.90% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 14.31% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 9.53% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 3.88% |
| 10 | Glucotrack | 547,659.96 | -25.38 Mn | - | -2,942.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,942.41% |
| Dec 31, 2025 | -576.81% |
| Sep 30, 2025 | -341.75% |
| Jun 30, 2025 | -217.83% |
| Mar 31, 2024 | -491.10% |
| Dec 31, 2023 | -162.30% |
| Sep 30, 2023 | -89.83% |
| Jun 30, 2023 | -120.69% |
| Mar 31, 2023 | -745.04% |
| Dec 31, 2022 | -247.25% |
| Sep 30, 2022 | -167.68% |
| Jun 30, 2022 | -120.93% |
| Mar 31, 2022 | -90.28% |
| Dec 31, 2021 | -69.32% |
| Sep 30, 2021 | -49.52% |
| Jun 30, 2021 | -45.79% |
| Mar 31, 2021 | -38.20% |
| Dec 31, 2020 | -33.09% |
| Sep 30, 2020 | 40.77% |
| Jun 30, 2020 | 37.98% |
API Access
Glucotrack Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GCTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GCTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GCTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();